| Literature DB >> 34959442 |
Abstract
A large number of people suffer from alopecia or hair loss worldwide. Drug-based therapies using minoxidil and finasteride for the treatment of alopecia are available, but they have shown various side effects in patients. Thus, the use of new therapeutic approaches using bioactive products to reduce the risk of anti-hair-loss medications has been emphasized. Natural products have been used since ancient times and have been proven safe, with few side effects. Several studies have demonstrated the use of plants and their extracts to promote hair growth. Moreover, commercial products based on these natural ingredients have been developed for the treatment of alopecia. Several clinical, animal, and cell-based studies have been conducted to determine the anti-alopecia effects of plant-derived biochemicals. This review is a collective study of phytochemicals with anti-alopecia effects, focusing mainly on the mechanisms underlying their hair-growth-promoting effects.Entities:
Keywords: alopecia; hair growth; natural product
Year: 2021 PMID: 34959442 PMCID: PMC8706577 DOI: 10.3390/pharmaceutics13122163
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321
Bioactive components from plants with hair-growth-promoting therapeutic effects.
| Botanical Name | Parts Used | Bioactive Components | Type of Extract | Ref |
|---|---|---|---|---|
| - | Sinapic acid | - | [ | |
| Leaves | Icariin | - | [ | |
| Whole plant | Corilagin, gallic acid | Methanolic extract | [ | |
| Unprocessed olive fruit and leaves | Oleuropein | - | [ | |
| - | Caffeine | - | [ | |
| Floret | Hydroxysafflor yellow A | Ethanolic extract | [ | |
| Whole plant | Linoleic acid, β-sitosterol, bicyclo(10.1.0)tridec-1-ene | Supercritical fluid extraction system | [ | |
| - | Quercitrin | - | [ | |
| Roots | L-maackiain, medicarpin | Methanolic extract | [ | |
| - | Shikimic acid |
| [ | |
| Seed | Procyanidin B-3 | Aceton extract | [ | |
| - | Ginsenoside Rb1 | - | [ | |
|
| Whole plant | Anthraquinone, flavonoids, tannin, saponins | Ethanolic extract | [ |
|
| - | α-Terpinyl acetate, sabinene, isobornyl acetate, limonene | Oil | [ |
|
| Roots | 2,3,5,4′-Tetrahydroxystilbene2-O-β-D-glucoside, emodin | Ethanolic extract | [ |
| Whole plant | Oregonin | Ethanolic extract | [ | |
|
| Seed | Myristoleic acid | Ethanolic extract | [ |
|
| Seed | Linoleic acid | Ethanolic extract | [ |
|
| - | Liposomal honokiol | - | [ |
| Roots | Decursin | Ethanolic extract | [ | |
| - | 3-Deoxysappanchalcone | - | [ | |
|
| Whole plant | 7-hydroxycoumarin, protocatechuate acid, ferulic acid, protocatechuic acid and epicatechin | Ethanolic extract | [ |
| Whole plant | Linoleic acid, β-sitosterol | Supercritical fluid extraction system | [ | |
|
| Leaves | Kaempferol, isoquercetin | Hot water extract | [ |
| - | 3,4,5-tri-O-caffeoylquinic acid | - | [ | |
|
| Whole plant | Octaphlorethol A | Ethanolic extract | [ |
| Nut oil | α-tocopherol, vitamin E β-sitosterol, linoleic acid, oleic acid | Pressing the seeds | [ | |
| - | Costunolide | - | [ | |
|
| - | Morroniside | - | [ |
|
| - | Timosaponin BII | - | [ |
| Whole plant | Flavonoids, monoterpenoids, sesquiterpenoids, diterpenoids, triterpenes, phenolic acids | Methanolic extract | [ | |
|
| Whole plant | Apo-9′-fucoxanthinone | Ethanolic extract | [ |
|
| Whole plant | Soyasaponin I, kaikasaponin III | Ethanolic extract | [ |
| Leaves | Myricitrin, isoquercitrin, quercitrin, myricetin, afzelin, quercetin, kaempferol, amentoflavone, hinokiflavone | Ethanolic extract, aqueous extract | [ | |
|
| Rhizome | Ginsenoside Ro | Ethanolic extract | [ |
| Leaves | Physcion | - | [ | |
|
| Leaves | 12-methoxycarnosic acid | Ethanolic extract | [ |
|
| Heartwood | Avicequinone C | Methanolic extract | [ |
|
| Whole plant | Dieckol | Enzymatic hydrolysis reaction | [ |
| - | Epigallocatechin-3-Gallate | - | [ | |
| Roots | Ginsenosides | Ethanolic extract | [ | |
|
| - | Fatty acids, phytosterols | - | [ |
Figure 1Interactions between herbs and their mechanisms for hair-growth-promoting efficacies.
Studies of hair-growth-promoting effects using natural products or their extracts.
| Natural Products | Experimental Model | Treatment | Effects | Ref |
|---|---|---|---|---|
| Sinapic acid | Human | 10, 50, and 100 μM | Induction of cell proliferation and cell cycle progression; activation of Akt and GSK-3β/β-catenin signaling; increased expression of VEGF and IGF-1 | [ |
| Icariin | Cultured | 10 and 20 μM | Induction of hair shaft elongation and prolonged anagen phase; increase of IGF-1 production and expression | [ |
| Cultured | 10 and 20 μM | |||
| C57BL/6 mice | 0.01 | |||
| Human | 9.8–156.3 ppm | Induction of cell proliferation and migration; induced expression of Ki-67 protein, HGF, and VEGF in vitro; reduced number of mast cells and the expression of TGF-β1 in mouse skin | [ | |
| C57BL/6 mice | 1000 ppm | |||
| Oleuropein | Human follicle | 10, 20, and 50 μM | Induction of cell proliferation; increase of LEF1 and cyclin D1 mRNA expression and β-catenin protein expression in vitro; induction of anagenic hair growth and Wnt/β-catenin pathway in vivo; upregulation of IGF-1, KGF, HGF, and VEGF gene expression in mice | [ |
| C57BL/6 mice | 0.4 mg/mouse/day | |||
| Caffeine | Cultured | 0.0005% | Increase of hair shaft elongation, anagen duration; increase of hair matrix keratinocyte proliferation and IGF-1 expression in hair follicles; increase of cell proliferation and IGF-1 expression in RSKs; inhibited apoptosis/necrosis and TGF-β2 protein secretion in RSKs | [ |
| Human | 0.005–1.250 mg/mL | Induction of cell proliferation in dermal papilla | [ | |
| Human hair | 0.005-1.250 mg/mL | |||
| Cultured hair follicles | 50, 100 and 200 μg/mL | |||
| Red Ginseng Oil | C57BL/6 mice | 10% | Increase of hair growth; upregulated β-catenin, Lef-1, Sonic hedgehog, Smoothened, Gli-1, Cyclin D1, and Cyclin E expression; reduced the protein level of TGF-β; enhanced the expression of Bcl-2 | [ |
| Quercitrin | Human dermal | 0.1, 1, 10, 100 nM and | Enhanced the cell viability and cellular energy metabolism; increase of expression of Bcl-2 and Ki67; upregulation of bFGF, KGF, PDGF-AA and VEGF; stimulated hair shaft growth in cultured hair follicles | [ |
| Cultured | 10−6, 10−5 and 10−4% | Induction of hair growth in vivo; increase of IGF-1 and KGF in vitro; decrease of 5a-reductase activity in vivo | [ | |
| Sprague-Dawley rats | 0.001, 0.01 and 0.01% | |||
| C57BL/6 mice | 1% | |||
| Shikimic acid | Human follicle | 0.1, 1, 10, 100 μM and 1 mM | Induction of hair growth in vivo; increase of | [ |
| Procyanidin B-3 | Cultured hair epithelial cells from C3H/HeNCrj mice | 0.1–100 μg/mL | Increased hair-growing activity in vitro and anagen-inducing activity in vivo; potential inhibitory effect of TGF-β1 | [ |
| C3H mice | 200 μL/day/mouse | |||
| Ginsenoside Rb1 | Cultured mink hair follicles | 5 and 10 μg/mL | Increase of the growth of hair follicles; upregulated the expression levels of VEGF-A and VEGF-R2, while attenuated the TGF-β1 expression; activation of PI3K/AKT/GSK-3β signaling pathway in hair follicles and DPCs. | [ |
| Cultured dermal | 10 μg/mL | |||
| Human follicle | 15.63–125 ppm | Enhanced cell proliferation and migration; high | [ | |
| C57BL/6 mice | 1000 ppm | |||
| C57BL/6 mice | 3% | Increase of ALP and γ-GT activities in the skin tissue; increase of IGF-1 mRNA expression; increase of VEGF and decrease of EGF expression in the skin tissue; increase of SCF expression | [ | |
| Human follicle | 10 and 100 μg/mL | Increased cell viability and mitochondrial activity; increase of Bcl-2 and decrease of BAD and DKK-1; increase of IGFBP2, PDGF and VEGF; prolonged the anagen of human hair follicles | [ | |
| Human follicle | 22, 66 and 200 μg/mL | Inhibition of apoptosis; increased IGF-1 and decreased TGF-β1 expression; decreased DHT production | [ | |
| Human follicle | 10–100 μg/mL | Increased Wnt reporter activity; increased β-catenin level; increased IGF-1, KGF, VEGF and HGF | [ | |
| Linoleic acid in | Human follicle | 3, 10 and 30 μg/mL | Activated Wnt/β-catenin signaling; induced cell growth by increasing the expression of cyclin D1 and CDK2; increased VEGF, IGF-1, HGF and KGF; inhibited DKK-1 | [ |
| Liposomal honokiol | C57BL/6 mice | 20 mg/mL | Promoted hair regrowth; accelerated the hair | [ |
| Decursin, | C57BL/6 mice | 2% | Induction of hair growth; decrease of TNF-and | [ |
| 3-Deoxysappanchalcone | Human follicle | 0.1–10 µM | Increased cell proliferation; increase of β-catenin and Tcf; increase of IL-6-induced phosphorylation and subsequent transactivation of STAT3, thereby increasing the expression of Cdk4, FGF and VEGF; promoted the anagen phase of hair growth in C57BL/6 mice | [ |
| 3 mM | ||||
|
| Human follicle | 1.25–40 μg/mL | Promoted cell proliferation; enhanced TCF/LEF-luciferase activity and increased the level of β-catenin protein; inhibited IL4-induced STAT6 phosphorylation; increased hair count after using the hair tonic for 12 weeks | [ |
| Red Ginseng Oil | C57BL/6 mice | 50% | Induction of hair growth; upregulated expression of β-catenin, phospho-GSK3β, Lef-1, Gli-1, Smoothened, Cyclin D1, Cyclin E, IGF-1 and VEGF; protective effect against UVC-induced skin damage in SKH-1 hairless mice by inhibiting inflammation and apoptosis | [ |
|
| C57BL/6 mice | 5.05 mg/cm2/day | Induction of hair growth including hair number and size of hair follicles; induction of β-catenin and Shh protein expression | [ |
| 3,4,5-tri-O-caffeoylquinic acid | Human follicle | 5, 10, 15 and 25 μM | Increase of β-catenin in vitro and in vivo; upregulation in hair growth-associated genes using microarray | [ |
|
| Cultured rat | 1, 10, and 100 μg/mL | Induction of anagen progression of the hair | [ |
| C57BL/6 mice | 15.06, 30.13, and 60.26 mg/cm2/day | Increase of hair growth; increase of Wnt 10b, β-catenin, and GSK-3β | [ | |
| KM mice | 0.47–60.26 mg/cm2/day | |||
| Costunolide | Human follicle | 0.1, 0.3, 1, and 3 μM | Increase of cell proliferation in vitro; inhibited | [ |
| Morroniside | Cultured outer root sheath cells | 1 and 10 µM | Enhanced outer root sheath cell proliferation | [ |
| Timosaponin BII | C57BL/6 mice | 0.5% | Induced hair growth; increased expression of | [ |
| Human follicle | 7.8, 15.6, and 31.3 μg/mL | Increased cell proliferation; increased HGF | [ | |
|
| C57BL/6 mice | 0.1, 1, and 10 μg/mL | Increase of the hair-fiber lengths and anagen | [ |
| Puerariae Flos | Wistar/ST rats | 50, 200, and 500 μg/mL | Increase of hair re-growth effect in testos | [ |
|
| Sprague-Dawley rats | 0.02–2.5 μmol/L | Increase of hair growth; increase of Wnt 10b, β-catenin, and GSK-3β | [ |
| Ginseng | Wistar rats | Ginseng rhizome | Induced hair re-growth in vivo; inhibitory | [ |
| Physcion | Sprague-Dawley ratsC57BL/6 mice | 12.5–100 µM5 mg/mouse/day | Inhibited the 5a-reductase activity; hair | [ |
| Wistar rats | 50, 200, and 500 μg/mL 2 mg/mouse/day | Improved hair regrowth in C57BL/6NCrSlc | [ | |
| Avicequinone C | Human hair dermal papilla cells | 5 and 10 µg/mL | Decreased 5a-reductase activity | [ |
| Cultured rat | 0.01–10 µg/mL | Increased hair-fiber length and anagen pro | [ | |
| Epigallocatechin-3-Gallate | Cultured mink | 0.1–5 µM | Promoted hair follicle growth in DPCs and | [ |
| Cultured outer root sheath keratinocytes | 20 ppm | Increased proliferation and inhibited apopto | [ | |
| Human keratinocyte cells | 1, 5, 25, and 100 μg/ mL | Increased cell viabilities; stimulated hair folli | [ |